project id: TCGA-MESO; case submitter id: TCGA-3H-AB3T; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.34; rna integrity number: 9.2; age at index: 79; days to birth: -28925; days to death: 414; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1930; year of death: 2010; age at diagnosis: 28925; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C45.0; last known disease status: not reported; morphology: 9053/3; primary diagnosis: Mesothelioma, biphasic, malignant; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pleura, NOS; synchronous malignancy: No; tissue or organ of origin: Pleura, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1709; initial weight: 80.0; oct embedded: false; preservation method: Unknown; sample id: 9e43d37d-b244-4a37-9e41-cfbd27008ffe; sample submitter id: TCGA-3H-AB3T-01A; percent lymphocyte infiltration: 70.0; percent monocyte infiltration: 10.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 20.0; section location: TOP;